Decolonisation of MRSA using the FlatPlaSter plasma device.
Cold atmospheric plasma treatment of MRSA (BAA-44) (106–7/ml) applied to ex vivo skin using the FlatPlaSter device. Different plasma treatment times were tested [min]. A CFU assay was performed immediately after the plasma treatment. Black dotted line: baseline of viable bacteria per ml; red dotted line: reduction of three log10 steps of viable bacteria (99.9%); green dotted line: reduction of five log10 steps of viable bacteria (99.999%). (n = 6, median ± interquartile range).